Seah, J.-A. et al. 2013. Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. Canadian Urological Association Journal. 7, 9-10 (Oct. 2013), 312–8. DOI:https://doi.org/10.5489/cuaj.1506.